Omega Fund Investments

Omega Fund has invested in 49 companies and its latest investment was eTheRNA on Aug 22, 2022

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

eTheRNA is a Belgium-based biotechnology company that researches and develops mRNA immunotherapies for the treatment of cancer.
$38.9M
Aug 22, 2022
-
Aerium is a Massachusetts-based biopharmaceutical firm that researches and commercializes antibodies and small-molecule antiviral drugs for the treatment of infectious diseases.
-
Mar 21, 2022
-
Endeavor BioMedicines is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and fibrosis lung diseases.
$101M
Feb 06, 2022
-
Aerium is a Massachusetts-based biopharmaceutical firm that researches and commercializes antibodies and small-molecule antiviral drugs for the treatment of infectious diseases.
-
Jun 15, 2021
-
Amunix is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer.
$117M
Mar 03, 2021
-

Frequently Asked Questions about Omega Fund

  1. What is Omega Fund investing in?

    Omega Fund has invested in 49 companies including eTheRNA, Aerium and Endeavor BioMedicines
  2. What company did Omega Fund invest in?

    Omega Fund invested in a total 49 companies including eTheRNA, Aerium and Endeavor BioMedicines
  1. What are the top 5 investments by Omega Fund?

    The top companies in which Omega Fund invested are eTheRNA, Aerium, Endeavor BioMedicines, Aerium and Amunix